Entry of ketoconazole into Candida albicans
- PMID: 3551831
- PMCID: PMC174699
- DOI: 10.1128/AAC.31.2.244
Entry of ketoconazole into Candida albicans
Abstract
To define characteristics that determine the entry of ketoconazole (KTZ) into Candida albicans cells, we studied the uptake of [3H]KTZ. The cells rapidly and markedly concentrated the drug: 30% of the final 80-fold intracellular concentration was attained in less than 1 min, and greater than 60% was attained in 10 min. Penetration of [3H]KTZ at an extracellular concentration higher than 0.1875 microM (0.1 microgram/ml) occurred by a simple diffusion mechanism. At lower concentrations, accumulation of the drug was an active, energy-requiring process, dependent at least in part on glycolysis, and pH dependent (optimal pH, 6.6). The active transport system had a high binding affinity (Km = 50 nM) and a high maximum velocity of uptake (Vmax = 1.4 mumol min-1 10(-7) cells). It was not possible to displace intracellular [3H]KTZ with high concentrations of unlabeled KTZ or other antifungal agents. These findings suggest that KTZ is rapidly taken up, highly concentrated, and tightly bound to cellular components of C. albicans.
Similar articles
-
Effects of the combination of ketoconazole and calcium channel antagonists against Candida albicans in vitro.Arzneimittelforschung. 1993 Jul;43(7):782-3. Arzneimittelforschung. 1993. PMID: 8369013
-
Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida albicans.Farmaco. 2004 Feb;59(2):163-7. doi: 10.1016/j.farmac.2003.11.018. Farmaco. 2004. PMID: 14871509
-
Effects of the combination of ketoconazole and calmodulin inhibitors against Candida albicans in vitro. Short communication.Arzneimittelforschung. 1993 Sep;43(9):1018-9. Arzneimittelforschung. 1993. PMID: 8240451
-
In vitro synergistic activity of ketoconazole with valproic acid against Candida species.Arzneimittelforschung. 1996 Sep;46(9):934-6. Arzneimittelforschung. 1996. PMID: 8876946
-
Topical ketoconazole: a systematic review of current dermatological applications and future developments.J Dermatolog Treat. 2019 Dec;30(8):760-771. doi: 10.1080/09546634.2019.1573309. Epub 2019 Feb 14. J Dermatolog Treat. 2019. PMID: 30668185
Cited by
-
Multiple efflux mechanisms are involved in Candida albicans fluconazole resistance.Antimicrob Agents Chemother. 1996 Dec;40(12):2835-41. doi: 10.1128/AAC.40.12.2835. Antimicrob Agents Chemother. 1996. PMID: 9124851 Free PMC article.
-
Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporter.Antimicrob Agents Chemother. 2003 Apr;47(4):1275-84. doi: 10.1128/AAC.47.4.1275-1284.2003. Antimicrob Agents Chemother. 2003. PMID: 12654658 Free PMC article.
-
Azole drugs are imported by facilitated diffusion in Candida albicans and other pathogenic fungi.PLoS Pathog. 2010 Sep 30;6(9):e1001126. doi: 10.1371/journal.ppat.1001126. PLoS Pathog. 2010. PMID: 20941354 Free PMC article.
-
Inactivation of the FCY2 gene encoding purine-cytosine permease promotes cross-resistance to flucytosine and fluconazole in Candida lusitaniae.Antimicrob Agents Chemother. 2005 Aug;49(8):3101-8. doi: 10.1128/AAC.49.8.3101-3108.2005. Antimicrob Agents Chemother. 2005. PMID: 16048910 Free PMC article.
-
Accumulation of an antidepressant in vesiculogenic membranes of yeast cells triggers autophagy.PLoS One. 2012;7(4):e34024. doi: 10.1371/journal.pone.0034024. Epub 2012 Apr 18. PLoS One. 2012. PMID: 22529904 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous